Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib preceding Mohs surgery for Basal Cell Carcinoma
NCT01898598Phase 2Terminated
- Sponsor
- Roche
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in basal cell carcinoma (BCC), sponsored by Roche. Started Jan 2014; status: terminated.
02
Drugs
vismodegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01898598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898598.